To order sections of the reports, contact Client Services.

This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e....

This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country.

The report also presents strategic profiles of current and emerging suppliers of nucleic acid testing products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products.

This 129-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e....

This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

The report analyzes a variety of cardiac biomarkers currently on the market, including those used to determine cholesterol and lipoprotein levels, cardiac necrosis, thrombosis, inflammation and genetic variants. Furthermore, a large number of biomarkers are currently under evaluation, and if successful, may provide cardiologists with a more comprehensive assessment of cardiovascular risk and prognosis....

The report analyzes current and potential world molecular diagnostics markets and advances in the field. The report forecasts future growth to 2015, and segments the market by test and geography....

There has been a significant transition in the diagnostic techniques created with increasing technological innovations. In the future, the focus will be on genetic study and disease predisposition, which will test patients' probability of acquiring a disease or a disorder, enabling precautionary steps....

Introduction

This report examines the opportunities presented to the developers of molecular diagnostics by the emergence of novel/variant pathogens and ways in which new molecular testing technologies are being translated into superior diagnostic products in areas such as healthcare-associated infections; HPV infections, blood-borne viral infections and respiratory viral infections.

Features and benefits

Understand the nature and limitations of traditional molecular diagnostics and the improved features of molecular testing technologies in development....

About This Report

This report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.� The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs....

This report provides a worldwide overview of the blood banking market,including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.

This report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

This report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers.

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking.

• Five-year U.S....